Matches in Wikidata for { <http://www.wikidata.org/entity/Q91835776> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q91835776 description "article scientifique publié en 2020" @default.
- Q91835776 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91835776 description "scientific article published on 01 April 2020" @default.
- Q91835776 description "wetenschappelijk artikel" @default.
- Q91835776 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q91835776 name "A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)" @default.
- Q91835776 name "A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)" @default.
- Q91835776 type Item @default.
- Q91835776 label "A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)" @default.
- Q91835776 label "A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)" @default.
- Q91835776 prefLabel "A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)" @default.
- Q91835776 prefLabel "A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)" @default.
- Q91835776 P1433 Q91835776-A46C6B79-1A1C-4FCA-BC33-0630295A7E52 @default.
- Q91835776 P1476 Q91835776-1FFF2057-7A7D-4047-9185-1E093CEFF43D @default.
- Q91835776 P2093 Q91835776-3F3A3B0B-B377-4796-926B-5ECD1003A75B @default.
- Q91835776 P2093 Q91835776-5543E896-F0A4-4634-86A4-9F87173711B4 @default.
- Q91835776 P2093 Q91835776-5585E22F-B447-4DF9-97AE-53A153C02429 @default.
- Q91835776 P2093 Q91835776-6813E8C9-BE48-49B3-85E7-CCE9C9781EC7 @default.
- Q91835776 P2093 Q91835776-76594C4C-3CA1-43D8-9DED-39F746769638 @default.
- Q91835776 P2093 Q91835776-B64C4691-DE0E-477D-8031-8E7F680B932A @default.
- Q91835776 P2093 Q91835776-C06240AA-A0B1-4426-815E-C8041E59FB1C @default.
- Q91835776 P2093 Q91835776-E1F9133A-F801-4D2C-AC87-8B5F0A06E3F0 @default.
- Q91835776 P2860 Q91835776-076F8A60-2293-4363-BFDF-081D44DECAF1 @default.
- Q91835776 P2860 Q91835776-1713D6B1-492A-4371-9567-D0931776019F @default.
- Q91835776 P2860 Q91835776-22BF1B2F-3439-4A52-AAEF-C78659D365A4 @default.
- Q91835776 P2860 Q91835776-247E1B3D-4AE2-428F-AC57-F065137FA284 @default.
- Q91835776 P2860 Q91835776-2B2E6276-595E-45B2-AAF4-2F2DF3969D45 @default.
- Q91835776 P2860 Q91835776-3322E89D-6772-4C2F-91FE-3D4C8DC9F3F6 @default.
- Q91835776 P2860 Q91835776-42E9A554-2B94-47A3-9EF1-C760ACB4DEDB @default.
- Q91835776 P2860 Q91835776-463DBAC6-B8F6-480F-9753-B8848D3E27EA @default.
- Q91835776 P2860 Q91835776-6D7A96E9-BC8E-445B-9DB6-8A388B0D15E4 @default.
- Q91835776 P2860 Q91835776-6F6C3692-E25B-4730-88C0-1412D4BE1447 @default.
- Q91835776 P2860 Q91835776-87E7BD43-8D26-491B-BE30-EFF64B519DF0 @default.
- Q91835776 P2860 Q91835776-C9AE6370-F34B-4800-BBDE-977CCD4386DD @default.
- Q91835776 P2860 Q91835776-CF310A57-DFD8-4ECE-B1A6-B5AE921BA452 @default.
- Q91835776 P2860 Q91835776-DBEE84B2-67B4-40F2-AF85-DB57946E128D @default.
- Q91835776 P304 Q91835776-6FF9DCC6-29EF-45AB-A9DE-7B8127F82C2F @default.
- Q91835776 P31 Q91835776-E0D8C902-29E6-440F-A315-FB2C43EB29FD @default.
- Q91835776 P356 Q91835776-29D6EAD1-E337-4334-806A-5CC95AD6BF72 @default.
- Q91835776 P433 Q91835776-CDDAE577-C830-4E1B-9889-EEF7A3C83A72 @default.
- Q91835776 P478 Q91835776-963AF2C0-0093-4B0D-B57F-E426D36D4958 @default.
- Q91835776 P577 Q91835776-D888FE51-E738-492A-81D5-448F4A3DCE87 @default.
- Q91835776 P698 Q91835776-B4243DDA-BE63-49C6-BB5D-FB83DF76DE5F @default.
- Q91835776 P921 Q91835776-56833AF4-6C6D-43A1-B12D-9F6EB1EFA98E @default.
- Q91835776 P921 Q91835776-E6C4B731-0854-48DC-9B25-C223914CFB88 @default.
- Q91835776 P932 Q91835776-ED8CE523-AC76-4F75-A75F-439FFD27D4CA @default.
- Q91835776 P356 S40259-019-00398-7 @default.
- Q91835776 P698 31820339 @default.
- Q91835776 P1433 Q4914612 @default.
- Q91835776 P1476 "A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)" @default.
- Q91835776 P2093 "Ann Alcasid" @default.
- Q91835776 P2093 "Anna Marina Liberati" @default.
- Q91835776 P2093 "Igor Aurer" @default.
- Q91835776 P2093 "Jeff P Sharman" @default.
- Q91835776 P2093 "Jeffery Robbins" @default.
- Q91835776 P2093 "Julie Ann Rosenberg" @default.
- Q91835776 P2093 "Kenichi Ishizawa" @default.
- Q91835776 P2093 "Tahira Khan" @default.
- Q91835776 P2860 Q33673144 @default.
- Q91835776 P2860 Q36425062 @default.
- Q91835776 P2860 Q37030703 @default.
- Q91835776 P2860 Q38676712 @default.
- Q91835776 P2860 Q41501755 @default.
- Q91835776 P2860 Q42372516 @default.
- Q91835776 P2860 Q47582438 @default.
- Q91835776 P2860 Q48083818 @default.
- Q91835776 P2860 Q48619267 @default.
- Q91835776 P2860 Q52801688 @default.
- Q91835776 P2860 Q53189779 @default.
- Q91835776 P2860 Q58565563 @default.
- Q91835776 P2860 Q73132182 @default.
- Q91835776 P2860 Q87412164 @default.
- Q91835776 P304 "171-181" @default.
- Q91835776 P31 Q13442814 @default.
- Q91835776 P356 "10.1007/S40259-019-00398-7" @default.
- Q91835776 P433 "2" @default.
- Q91835776 P478 "34" @default.
- Q91835776 P577 "2020-04-01T00:00:00Z" @default.
- Q91835776 P698 "31820339" @default.
- Q91835776 P921 Q123251 @default.
- Q91835776 P921 Q412323 @default.
- Q91835776 P932 "7113218" @default.